Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 5, 2012, Pages 660-664

  Kitada, Seigo ^a   Uenami, T ^a   Yoshimura, K ^a   Tateishi, Y ^a   Miki, K ^a   Miki, M ^a   Hashimoto, H ^a   Fujikawa, T ^a   Mori, M ^a   Matsuura, K ^a   Kuroyama, M ^a   Maekura, R ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Chest radiography; Non tuberculous mycobacteria; Retrospective cohort study

Indexed keywords

ANTIMYCOBACTERIAL AGENT; MACROLIDE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BODY MASS; BRONCHIECTASIS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; DISEASE DURATION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; JAPAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM INTRACELLULARE AVIUM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BODY MASS INDEX; BRONCHIECTASIS; COHORT STUDIES; DISEASE PROGRESSION; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACROLIDES; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859716195     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0534     Document Type: Article

References (13)

1. Griffith D E, Aksamit T, Brown-Elliott B A, et al ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367- 416.
2. Marras T K, Daley C L. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002; 23: 553-567.
3. Marras T K, Chedore P, Ying A M, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007; 62: 661-666. (Pubitemid 47235003)
4. Martín-Casabona N, Bahrmand A R, Bennedsen J, et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004; 8: 1186-1193. (Pubitemid 39371831)
5. Sakatani M, Nakajima Y. Treatment of non-tuberculous pulmonary mycobacteriosis. Kekkaku 2006; 81: 35-50.
6. Sakatani M. Non-tuberculous mycobacteriosis; the present status of epidemiology and clinical studies. Kekkaku 1999; 74: 377-384. (Pubitemid 29226007)
7. Prince D S, Peterson D D, Steiner R M, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868. (Pubitemid 19238618)
8. American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156 (2 Pt 2): S1-S25.
9. The Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis 2002; 6: 628-634.
10. The Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense, and M. xenopi in HIV-negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001; 56: 167-172.
11. Yamazaki Y, Kubo K, Takamizawa A, Yamamoto H, Honda T, Sone S. Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. Am J Respir Crit Care Med 1999; 160: 1851-1855. (Pubitemid 30004686)
12. Tanaka E, Kimoto T, Tsuyuguchi K, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999; 160: 866-872. (Pubitemid 29442022)
13. Kobashi Y, Matsushima T. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study. Respiration 2007; 74: 394- 400.